Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Japanese group investigates use of PTPase inhibitors in allergic diseases

Feb. 27, 2002

Results of extension study of infliximab in psoriasis patients

Feb. 25, 2002

HE-2500 effective in preclinical model of psoriasis; clinical trials planned

Feb. 22, 2002

EpiDex to be regulated as a medical device in the U.S.

Feb. 21, 2002

New antedrugs with therapeutic potential in psoriasis

Feb. 15, 2002

Six-month follow-up results with OrCel treatment of venous ulcers

Feb. 8, 2002

Vitamin D analogues for the treatment of dermatoses

Feb. 7, 2002

Propecia significantly reduces hair loss, restores hair growth in men with androgenic alopecia

Feb. 4, 2002

Alesse approved by Canadian authorities for treatment of acne

Feb. 1, 2002

Novel group of compounds identified as chemokine antagonists

Jan. 28, 2002

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...